JPMorgan Chase & Co. Increases RXO (NYSE:RXO) Price Target to $25.00

RXO (NYSE:RXOGet Free Report) had its price target increased by analysts at JPMorgan Chase & Co. from $16.00 to $25.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential downside of 5.77% from the stock’s current price.

A number of other research firms also recently weighed in on RXO. Stephens reissued an “equal weight” rating and set a $22.00 target price on shares of RXO in a research report on Monday, May 6th. Susquehanna lifted their target price on RXO from $15.00 to $16.00 and gave the stock a “negative” rating in a research report on Monday, March 25th. Raymond James started coverage on RXO in a research report on Wednesday, May 15th. They set a “market perform” rating on the stock. TD Cowen lifted their target price on RXO from $19.00 to $20.00 and gave the stock a “hold” rating in a research report on Friday, May 3rd. Finally, Benchmark reaffirmed a “hold” rating on shares of RXO in a report on Wednesday, June 12th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $20.80.

Get Our Latest Stock Report on RXO

RXO Trading Down 0.8 %

RXO stock opened at $26.53 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.14 and a current ratio of 1.14. The business’s 50-day simple moving average is $21.94 and its 200-day simple moving average is $21.55. The firm has a market capitalization of $3.12 billion, a PE ratio of -294.78, a PEG ratio of 10.24 and a beta of 1.41. RXO has a 52 week low of $16.94 and a 52 week high of $28.13.

RXO (NYSE:RXOGet Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.01. The business had revenue of $913.00 million for the quarter, compared to analyst estimates of $929.50 million. RXO had a positive return on equity of 3.23% and a negative net margin of 0.29%. The firm’s revenue for the quarter was down 9.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.11 earnings per share. Equities research analysts forecast that RXO will post 0.18 earnings per share for the current year.

Insider Activity

In other news, major shareholder Mfn Partners, Lp bought 5,139 shares of the business’s stock in a transaction dated Friday, April 12th. The stock was bought at an average price of $20.39 per share, for a total transaction of $104,784.21. Following the completion of the purchase, the insider now owns 15,593,694 shares of the company’s stock, valued at approximately $317,955,420.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last 90 days, insiders bought 1,128,060 shares of company stock worth $22,099,090. Insiders own 1.80% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. MFN Partners Management LP raised its position in shares of RXO by 19.8% during the 1st quarter. MFN Partners Management LP now owns 15,588,555 shares of the company’s stock valued at $340,922,000 after acquiring an additional 2,580,330 shares during the last quarter. Vanguard Group Inc. raised its position in shares of RXO by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 13,294,483 shares of the company’s stock valued at $290,750,000 after acquiring an additional 45,977 shares during the last quarter. Swedbank AB bought a new stake in shares of RXO during the 1st quarter valued at $76,982,000. Douglas Lane & Associates LLC raised its position in shares of RXO by 2.0% during the 2nd quarter. Douglas Lane & Associates LLC now owns 2,698,525 shares of the company’s stock valued at $70,566,000 after acquiring an additional 52,378 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of RXO by 5.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,869,583 shares of the company’s stock valued at $43,489,000 after acquiring an additional 93,885 shares during the last quarter. Institutional investors own 92.73% of the company’s stock.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

See Also

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.